International Flavors & Fragrances Inc. IFF · NYSE
$82.61 -4.34% (-$3.75)
Summary
35 / 100 · Bulios Score
What speaks for it
- It passes 8 of the 9 points of the Piotroski financial health test.
What to watch
- It pays out more in dividends than it earns: 332% of profit.
- The share price is above the Bulios Fair Price.
- Revenue fell by 4.3% a year over the last 3 years.
- Repaying its net debt would take 4.6 years of operating profit.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 179.1 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 16% a year over 5 years. Over the last 3 years it fell by 4.3% a year.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 61 USD
- Research and development 7.4 USD
- Sales and administration 23 USD
- Taxes and other 6.4 USD
- Net profit 1.3 USD
Net profit, industry median (Chemicals - Specialty) 6.0 USD
Out of every 100 USD of revenue, 1.3 USD is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 12.5 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, at risk- Yield
- 1.85%
- Paid out of profit
- 332%
You receive $1.60 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 25
- Hold 8
- Sell 1
Today's price within the analysts' price targets
The average target of $98.14 is 19% above today's price. 74% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Food Ingredients 30%
- Taste 23%
- Scent 23%
- Health & Biosciences 21%
- Pharma Solutions 3.4%
By region
- EMEA 27%
- North America 23%
- UNITED STATES 22%
- Asia 18%
- Latin America 10%
Food Ingredients brings in 30% of revenue. Scent grew fastest, by 2.4% a year.
Segments in detail